Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

5 Critical Biotech Drug Dates and Events for December
24/7 Wall St
Monday, December 1, 2014 - 4:45pm
tags:
biotech, Incyte, ruxolitinib, Cubist Pharma, ceftolozane/tazobactam, Biocryst, peramivir, Vertex Pharmaceuticals, Kalydeco, Pozen, PA8140/PA32540
Pfizer closes $635M vaccines purchase from Baxter
Yahoo/AP
Monday, December 1, 2014 - 4:42pm
tags:
Pfizer, vaccines, M&A, Baxter International
Exelixis drops 15% after prostate cancer drug candidate fails Phase 3
Seeking Alpha
Monday, December 1, 2014 - 11:31am
tags:
Exelixis, prostate cancer, cabozantinib
Want to relocate to Asia? What pharma recruiters really look for
In-Pharma Technologist
Monday, December 1, 2014 - 11:28am
tags:
Asia, jobs, pharma recruiters
Bristol-Myers Cuts Jobs in China as Drug Makers Rethink Marketing
WSJ Pharmalot
Monday, December 1, 2014 - 11:22am
tags:
Bristol-Myers Squibb, China, layoffs
J&J bets up to $277M on a prospect from its R&D farm system
Fierce Biotech
Monday, December 1, 2014 - 11:19am
tags:
JNJ, R&D, Modern Biosciences
FDA to Review Eylea for Diabetic Retinopathy
Monthly Prescribing Reference
Monday, December 1, 2014 - 10:36am
tags:
FDA, Eylea, diabetic retinopathy, Regeneron
Should The FDA Force Drug Makers To Discuss Their Clinical Trials?
Forbes
Monday, December 1, 2014 - 10:17am
tags:
FDA, clinical trials
Using Doctors With Troubled Pasts to Market a Painkiller
NY Times, NY
Monday, December 1, 2014 - 10:13am
tags:
physicians, painkillers, INSYS Therapeutics
Novartis’s Gilenya Fails to Help Hard-to-Treat Form of MS
Bloomberg
Monday, December 1, 2014 - 9:59am
tags:
Novartis, Gilenya, MS, multiple sclerosis
Mylan to Manufacture, Distribute Gilead Sciences HIV Drug
Marketwatch
Monday, December 1, 2014 - 9:58am
tags:
Mylan Labs, HIV, Gilead Sciences, tenofovir
Northwest Biotherapeutics: An Analysis Of What We Know About DCVax Direct
Seeking Alpha
Monday, December 1, 2014 - 9:17am
tags:
DCVax Direct, Northwest Biotherapeutics, cancer, immuno-oncology
Bristol-Myers Squibb and Pfizer Inc.'s Bet on This Small Biotech Stock Could Pay Off
Motley Fool
Monday, December 1, 2014 - 9:12am
tags:
Pfizer, Bristol-Myers Squibb, Portola Pharmaceuticals, andexanet alfa
POZEN Inc. and Sanofi US Mutually Agree to Terminate U.S. Partnership for PA8140/PA32540
Yahoo
Monday, December 1, 2014 - 9:02am
tags:
Pozen, Sanofi, Yosprala
Fresh from a $3.85B deal, biotech CEO sets sights on the next big thing
Fierce Biotech
Monday, December 1, 2014 - 8:19am
tags:
Ron Renaud, Merck, Idenix, RaNA, RNA
AbbVie adds children's AIDS drugs to shared patent pool
Yahoo/Reuters
Monday, December 1, 2014 - 7:56am
tags:
AbbVie, AIDS, patents
AstraZeneca and Lilly move Alzheimer's drug into big trial
Yahoo/Reuters
Monday, December 1, 2014 - 7:39am
tags:
AstraZeneca, Eli Lilly, Alzheimer's disease, AZD3293, LY3314814
Patients Feel The Pinch Of Higher Generic Drug Prices
CBS
Sunday, November 30, 2014 - 10:21am
tags:
generics
China Approves Emergency Ebola Tests Just in Case
Wallstreet OTC
Sunday, November 30, 2014 - 10:18am
tags:
Ebola
GlaxoSmithKline Said to Plan Reorganization, U.S. Cuts
Bloomberg
Saturday, November 29, 2014 - 11:11pm
tags:
GSK, layoffs, reorganization

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.